Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.68 +0.05 (+3.07%)
At close: Sep 30, 2026 · 4:00 PM EDT

Transcode Therapeutics (RNAZ) Preferred Shares (2026)

Updated

Transcode Therapeutics (RNAZ) posted Preferred Shares of $121.00 for Q2 2026, unchanged from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Preferred Shares (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Transcode Therapeutics 1.70 Mn 1.70 Mn - 121.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121.00
Mar 31, 2026 121.00
API Access

Transcode Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=RNAZ&period=max&api_key=YOUR_API_KEY